Weight loss medication

Weight loss medication is a prescription or over-the-counter drug, such as semaglutide or phentermine, that doctors use to help patients reduce body weight by affecting appetite or metabolism. Insurance providers, including UnitedHealthcare and Aetna, may cover FDA-approved weight loss drugs like Wegovy and Saxenda for patients with a BMI ≥30 or ≥27 with obesity-related conditions, as noted by Your Insurance Info.

The average monthly out-of-pocket cost for GLP-1 medications, such as Ozempic and Zepbound, ranges from $900 to $1,300 without insurance. Most employer-sponsored health plans exclude coverage for weight loss drugs unless a physician documents medical necessity due to comorbidities like type 2 diabetes or hypertension.

Medicare Part D generally does not cover anti-obesity medications such as Contrave or Qsymia. Medicaid programs in 10 states (e.g.

California, Michigan) offer some coverage for specific weight loss medications when prescribed for qualifying diagnoses. To get prior authorization, insurers typically require documentation of failed lifestyle interventions and adherence to FDA prescribing criteria.

Weight loss medication coverage exclusions often appear in policy documents’ prescription drug lists under “anti-obesity agents.” Some marketplace plans list covered formulary drugs online by National Drug Code (NDC), enabling applicants to verify inclusion before enrollment. Appeals for denied claims require submission of medical records proving necessity per the insurer’s published clinical guidelines.

Employers adding GLP-1s to formularies often see pharmacy benefit costs increase by up to 8%, according to Milliman data from 2023.